Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 2,891 |
|
|||||
| News | - | ||||||
| Day High | 2.11 | Low High |
|||||
| Day Low | 2.00 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Indaptus Therapeutics Inc | INDP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.015 | 0.75% | 2.02 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.02 | 2.00 | 2.11 | 2.02 | 2.005 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 89 | 2,891 | US$ 2.03 | US$ 5,866 | - | 1.57 - 4.08 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:28:45 | 1 | US$ 2.06 | USD |
Indaptus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 82.23M | 8.54M | - | 0 | -15.42M | -1.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Indaptus Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INDP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.22 | 2.28 | 1.9719 | 2.06 | 10,713 | -0.20 | -9.01% |
| 1 Month | 2.2998 | 2.95 | 1.9719 | 2.51 | 24,057 | -0.2798 | -12.17% |
| 3 Months | 1.61 | 2.95 | 1.57 | 2.32 | 94,101 | 0.41 | 25.47% |
| 6 Months | 2.56 | 3.25 | 1.57 | 2.30 | 51,137 | -0.54 | -21.09% |
| 1 Year | 2.62 | 4.08 | 1.57 | 2.33 | 33,400 | -0.60 | -22.90% |
| 3 Years | 10.10 | 28.8299 | 1.25 | 9.30 | 463,591 | -8.08 | -80.00% |
| 5 Years | 10.10 | 28.8299 | 1.25 | 9.30 | 463,591 | -8.08 | -80.00% |
Indaptus Therapeutics Description
| Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York. |
